Overview Request Sample Pages Request Customization Download PDF
You are viewing: UK Flow Cytometry Market analysis
Part of: Flow Cytometry Market (Global)

The UK Flow Cytometry Market was valued at $310.3 Million in 2025 and projected to reach to $616.9 Million by 2030, representing a compound annual growth rate of 9.0%. The UK flow cytometry market is positioned for sustained growth through 2030, driven by increasing clinical adoption in hematology, immunology, and oncology diagnostics.

UK Flow Cytometry Market (2025-2030) : Size and Share
logo-mobile
CAGR of
cagr-Chart
USD Million
MARKET SNAPSHOT
Market Size in USD 26.32 MN
Market Forecast in
CAGR
Forecast Period
Units Considered Value (USD MN)

UK Flow Cytometry Market Trends and Insights

  • The UK's advanced healthcare infrastructure, coupled with increasing adoption of flow cytometry in clinical diagnostics and research applications, is driving this accelerated expansion.
  • The UK market benefits from strong investment in life sciences research, rising prevalence of hematologic and immunologic disorders, and growing demand for precision medicine solutions across NHS facilities and private laboratories..

Key Market Statistics

  • CAGR (2025-2030) 9.0% CAGR
  • Market Size, 2025 ~USD 310.3 Million
  • Forecast, 2030 ~USD 616.9 Million
  • Country UK

UK Flow Cytometry Market Overview

Market Valuation Growth :

The UK flow cytometry market is valued at $310.3 million in 2025 and is projected to reach $616.9 million by 2030, demonstrating a strong 9.0% CAGR, outpacing the global average of 8.7%.

Advanced Healthcare Infrastructure :

The UK's well-established NHS and private healthcare systems provide robust adoption pathways for flow cytometry technologies in clinical diagnostics, immunology, and oncology applications.

Research & Clinical Expansion :

Increasing utilization of flow cytometry in UK research institutions, diagnostic laboratories, and clinical settings is driving demand for advanced cell analysis and immunophenotyping solutions.

Regulatory & Innovation Support :

UK regulatory frameworks and investment in life sciences innovation create favorable conditions for flow cytometry adoption across NHS trusts, private hospitals, and academic research centers.

UK Flow Cytometry Market Dynamics

  • NHS modernization initiatives and rising demand for personalized medicine are accelerating technology integration across diagnostic laboratories and research institutions.
  • The market benefits from strong healthcare spending, advanced infrastructure, and a skilled workforce capable of implementing sophisticated flow cytometry applications.
  • Continued investment in cancer research, immunological studies, and infectious disease diagnostics will further propel market expansion.
  • Competition among manufacturers and rising demand for cost-effective solutions are expected to drive innovation and market consolidation..

Related Ecosystem

Biotechnology

Top Technologies
  • Reagents
  • Polymerase Chain Reaction (PCR)
  • Stem Cells
  • Assay Kits
  • Flow Cytometers
Top Companies
  • Thermo Fisher Scientific Inc.
  • Merck KGaA
  • Danaher Corporation
  • Agilent Technologies, Inc.
  • Bio-Rad Laboratories, Inc.

    Key Takeaways

    • The UK flow cytometry market is projected to double from $310.3M (2025) to $616.9M (2030) at a 9.0% CAGR.
    • The UK's advanced healthcare system and NHS infrastructure support widespread adoption of flow cytometry technologies.
    • Rising incidence of blood cancers and immune disorders in the UK is driving clinical demand for flow cytometry diagnostics.
    • The UK market is characterized by strong R&D investment and increasing integration of flow cytometry in personalized medicine initiatives.

    Flow Cytometry Market Report Scope

    Report Metric Details
    Base Year 2025
    Fastest Growing Segment ANTIBODIES (Type)
    Forecast Period 2025–2030
    Growth Rate CAGR of 8.7% from 2025 to 2030
    Largest Segment REAGENTS & CONSUMABLES (Offering)
    Market Size Base Year (Billions) ~USD 5.05 (2025)
    Revenue Forecast (Billions) ~USD 7.67 (2030)
    Segments Covered Offering, Type

    UK Flow Cytometry Market Report Segmentation

    2 segment dimensions are covered across the global market.

    By Offering

    • Accessories
    • Instruments
    • Reagents & Consumables
    • Services
    • Software

    By Type

    • Antibodies
    • Assays & Kits
    • Cell Analyzers
    • Cell Sorters
    • Other Reagents & Consumables

    UK: FLOW CYTOMETRY MARKET, BY END USER, 2023–2033

    Segment20232024202520262027202920312033CAGR (%)
    ACADEMIC & RESEARCH INSTITUTES120.9125.3131.3140.7153.8183.8222.5275.89.7
    HOSPITALS & CLINICAL TESTING LABORATORIES110.4113.6118125.6136.2160.4191.3233.78.9
    PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES58.659.5616468.578.390.7107.57.3
    TOTAL289.9298.4310.3330.2358.5422.5504.6616.99

    Target Audience

    • Medical Device Manufacturers : Flow cytometry equipment and reagent manufacturers need UK-specific market data to develop localized go-to-market strategies, identify distribution partners, and optimize product portfolios for NHS and private sector demand.
    • Healthcare Providers & NHS Trusts : Hospital administrators and diagnostic laboratory directors require market insights to justify capital investments in flow cytometry systems, benchmark against peers, and plan technology upgrades aligned with clinical demand.
    • Research Institutions & Universities : UK academic centers and research organizations need market intelligence to secure funding, identify collaboration opportunities, and understand adoption trends in flow cytometry-dependent research areas.
    • Diagnostic Laboratory Operators : Independent and hospital-based diagnostic labs require UK market data to assess competitive positioning, evaluate technology investments, and identify growth opportunities in clinical testing services.
    • Healthcare Investors & Consultants : Private equity firms, management consultants, and healthcare investors need UK-specific market analysis to evaluate investment opportunities, assess portfolio company performance, and identify acquisition targets in the diagnostics sector.

    Key Companies in the UK Flow Cytometry Market

    CompanyHQOwnershipStrongest segments
    ABCAM PLCUnited KingdomPrivate CompanyPrimary and secondary antibodies,Conjugated antibodies and conjugation kits,Singleplex immunoassays,
    BECKMAN COULTERUnited StatesPrivate CompanyClinical core lab (chemistry, hematology, immunoassay, urinalysis, integrated systems),Flow cytometry and cellular analysis (clinical and research),Life science research tools (centrifugation, capillary electrophoresis, liquid handling, genomics),
    INTUITIVE SURGICAL INCUnited StatesPublic Companyda Vinci capital systems,da Vinci instruments, stapling, energy, and accessories,Service, training, and digital programs,
    BECTON, DICKINSON AND COMPANYUnited StatesPublic CompanyMedical Essentials (syringes, needles, IV and vascular access, sharps),Connected Care (infusion pumps, medication management, pharmacy automation, informatics),BioPharma Systems (prefillable drug delivery systems),
    DANAHER CORPORATIONUnited StatesPublic CompanyBiotechnology (bioprocessing and related solutions),Life Sciences (research tools and genomic medicines),Diagnostics (clinical instruments and consumables),
    THERMO FISHER SCIENTIFIC INC.United StatesPublic CompanyLife Sciences Solutions (reagents, instruments, consumables),Analytical Instruments,Specialty Diagnostics,
    AGILENT TECHNOLOGIES, INC.United StatesPublic CompanyLife Sciences and Diagnostics Markets,Agilent CrossLab,Applied Markets,
    SONY CORPORATIONJapanPublic CompanyGame & Network Services,Music,Pictures,
    BIO-RAD LABORATORIES, INC.United StatesPublic CompanyClinical Diagnostics,Life Science Research Instruments and Reagents,
    ENZO BIOCHEM INC.United StatesPrivate CompanyLabels, dyes, and genomic probes,Antibodies and immunoassays,Biochemicals and proteins,
    SYSMEX CORPORATIONJapanPublic CompanyHematology analyzers and reagents (XN-Series, XN-V, ProCyte Dx for Research),Coagulation diagnostics,Urinalysis and blood gas/electrolyte,
    CYTEK BIOSCIENCESUnited StatesPublic CompanyAurora / Aurora Evo / Aurora CS spectral systems,Northern Lights and conventional flow cytometers (Guava, Muse, easyCyte),Amnis imaging flow cytometers,
    BIOMéRIEUXFrancePublic CompanySyndromic and low-plex PCR (BIOFIRE, SPOTFIRE, ARGENE),Microbiology ID/AST systems and reagents (VITEK 2, VITEK MS, VITEK REVEAL, API, ETEST),Culture media, CHROMID range, and BACT/ALERT VIRTUO,
    SARTORIUS AGGermanyPublic CompanyBioprocess solutions (bioreactors, fermenters, filtration, process chromatography, fluid management),Lab products and services (filtration, purification, water systems, weighing, pipettes, microbiological testing, OEM),Analytical and cell analysis solutions (BLI, cytometry screening, PAT, live-cell imaging, SPR, cell selection),
    UNION BIOMETRICA, INC.United StatesPrivate CompanyCOPAS and related throughput instruments,Contract biological services and assay development,Consumables, support, and upgrades,
    TAKARA BIO INC.JapanPrivate CompanyGenetic and cellular research reagents,Instruments (PCR and cellular analysis devices),In vitro diagnostics (including COVID-19 testing),

    ABCAM PLC

    Abcam PLC is a United Kingdom-based private company founded in 1998 with 1,760 employees, specializing in life sciences research products and services.

    BECKMAN COULTER

    Beckman Coulter is a United States-based private company founded in 1935 with 11,900 employees, manufacturing laboratory instruments and diagnostic equipment.

    INTUITIVE SURGICAL INC

    Intuitive Surgical Inc. is a publicly traded United States company founded in 1995 with 17,021 employees, known for developing robotic-assisted surgical systems.

    BECTON, DICKINSON AND COMPANY

    Becton, Dickinson and Company is a publicly traded United States company founded in 1897 with 72,000 employees, manufacturing medical devices, laboratory equipment, and diagnostic products.

    DANAHER CORPORATION

    Danaher Corporation is a publicly traded United States conglomerate founded in 1969 with 59,000 employees, operating across multiple industries including life sciences and diagnostics.

    THERMO FISHER SCIENTIFIC INC.

    Thermo Fisher Scientific Inc. is a publicly traded United States company founded in 1956 with 125,000 employees, providing laboratory equipment, reagents, and analytical instruments globally.

    AGILENT TECHNOLOGIES, INC.

    Agilent Technologies, Inc. is a publicly traded United States company founded in 1999 with 18,000 employees, specializing in life sciences, diagnostics, and analytical instruments.

    SONY CORPORATION

    Sony Corporation is a publicly traded Japanese company founded in 1946 with 94,900 employees, operating across electronics, entertainment, and other diversified business segments.

    BIO-RAD LABORATORIES, INC.

    Bio-Rad Laboratories, Inc. is a publicly traded United States company founded in 1952 with 7,450 employees, manufacturing clinical diagnostics and life science research products.

    ENZO BIOCHEM INC.

    Enzo Biochem Inc. is a United States-based private company founded in 1976 with 131 employees, focused on molecular diagnostics and life sciences research.

    SYSMEX CORPORATION

    Sysmex Corporation is a publicly traded Japanese company founded in 1968 with 10,861 employees, manufacturing hematology and clinical diagnostics instruments.

    CYTEK BIOSCIENCES

    Cytek Biosciences is a publicly traded United States company founded in 1992 with 678 employees, developing flow cytometry and cell analysis technologies.

    BIOMéRIEUX

    bioMérieux is a publicly traded French company founded in 1963 with 14,894 employees, specializing in in vitro diagnostics and microbiology testing solutions.

    SARTORIUS AG

    Sartorius AG is a publicly traded German company founded in 1870 with 14,242 employees, manufacturing laboratory and bioprocess equipment for life sciences applications.

    UNION BIOMETRICA, INC.

    Union Biometrica, Inc. is a United States-based private company founded in 1998 with 21 employees, specializing in automated imaging and analysis systems for small organisms.

    TAKARA BIO INC.

    Takara Bio Inc. is a Japanese private company founded in 2002 with 1,779 employees, providing molecular biology reagents and biotechnology research tools.

    Reasons to Buy this Report

    • UK-Specific Market Sizing : Obtain precise valuation data for the UK market ($310.3M in 2025) with detailed forecasts through 2030, enabling accurate budget allocation and investment planning for UK operations.
    • Competitive Landscape Intelligence : Understand UK market dynamics, key players, and competitive positioning specific to the British healthcare system, NHS procurement patterns, and private sector adoption trends.
    • Growth Opportunity Identification : Identify high-growth segments within the UK market including clinical diagnostics, research applications, and emerging therapeutic areas with the strongest expansion potential.
    • Regulatory & Market Entry Strategy : Access insights on UK regulatory requirements, NHS approval pathways, reimbursement frameworks, and market entry strategies tailored to the British healthcare environment.
    • Strategic Partnership & Investment Decisions : Make informed decisions on UK partnerships, acquisitions, and investments with comprehensive data on market trends, customer needs, and growth drivers specific to the region.

    Frequently asked questions

    What is the current size of the UK flow cytometry market?

    The UK flow cytometry market is valued at $310.3 million in 2025 and is expected to grow significantly through 2030.

    What is the projected growth rate for the UK flow cytometry market?

    The UK flow cytometry market is expected to grow at a compound annual growth rate (CAGR) of 9.0% from 2025 to 2030.

    What will the UK flow cytometry market size be in 2030?

    The UK flow cytometry market is forecast to reach $616.9 million by 2030, representing a doubling of market value from 2025.

    What factors are driving growth in the UK flow cytometry market?

    Key drivers include increasing prevalence of hematologic disorders, rising adoption in clinical diagnostics, NHS investment in advanced diagnostics, and growing demand for precision medicine in the UK.

    How does the UK flow cytometry market compare to global trends?

    The UK market is growing at 9.0% CAGR, slightly outpacing the global average of 8.7%, reflecting strong healthcare infrastructure and research investment in the UK.

    RESEARCH METHODOLOGY

    This research study involved the extensive use of secondary sources, directories, and databases to identify and collect valuable information for the analysis of the global flow cytometry market. In-depth interviews were conducted with various primary respondents, including key industry participants, subject-matter experts, C-level executives of key market players, and industry consultants, to obtain and verify critical qualitative and quantitative information and assess the growth prospects of the market. The global market size estimated through secondary research was then triangulated with inputs from primary research to arrive at the final market size.

    Secondary Research

    Secondary research was used mainly to identify and collect information for the extensive, technical, market-oriented, and commercial study of the flow cytometry market. The secondary sources used for this study include the World Health Organization (WHO), the Organization for Economic Co-operation and Development (OECD), the World Bank, Eurostat, the National Institutes of Health (NIH), Institute for Health Metrics and Evaluation (US), International Society for Advancement of Cytometry (US), US FDA, Health Canada, EuroStemCell, German Cancer Research Center, NHS (UK), Cancer Research UK (UK), Stem Cell Foundation, French National Research Agency (France), Italian National Institute of Health, National Cancer Center Japan, Australasian Cytometry Society (Australia), the Cytometry Society (India), International Clinical Cytometry Society (US), and African Cancer Registry Network; Lens. Org. National Center for Biotechnology Information (NCBI), corporate filings such as annual reports, SEC filings, investor presentations, and financial statements; research journals; press releases; and trade, business, and professional associations, among others. These sources were also used to obtain key information about major players, market classification, and segmentation according to industry trends, regional/country-level markets, market developments, and technology perspectives.

    Primary Research

    Extensive in-depth interviews were conducted with various primary respondents, including key industry participants, subject-matter experts, C-level executives of key market players, and industry consultants, to obtain and verify the critical qualitative & quantitative information and assess the prospects of the market. Various primary sources from both the supply & demand sides of the market were interviewed to obtain qualitative and quantitative information.

    The following is a breakdown of interviews with the primary respondents.

    Flow Cytometry Market

    To know about the assumptions considered for the study, download the pdf brochure

    Market Size Estimation

    Both top-down and bottom-up approaches were used to estimate & validate the total size of the flow cytometry market. These methods were also used extensively to estimate the size of various subsegments in the market. The research methodology used to estimate the market size includes the following:

    Flow Cytometry Market

    Data Triangulation

    After estimating the overall market size from the market size estimation process, the total market was split into several segments and subsegments. To complete the overall market engineering process and arrive at the exact statistics for all segments and subsegments, data triangulation and market breakdown procedures were employed, wherever applicable. The data was triangulated by studying various factors and trends from both the demand and supply sides.

    Market Definition

    Flow cytometry is a laser-based technology used to measure & analyze multiple physical characteristics of microscopic particles, including cells (mammalian, plant, algae, yeast, and bacteria); cellular matter (enzymes, proteins, nuclei, RNA, and DNA); and latex beads. Several properties related to cellular structure and functions, such as cell size, cell cycle, cell viability, enzymatic activities, membrane potentials, cellular antigens, DNA/RNA, protein synthesis, and surface receptors, can be analyzed with the help of flow cytometry. Flow cytometry has several applications in scientific research and clinical diagnosis.

    Stakeholders

    • Flow cytometry equipment manufacturers, vendors, and distributors
    • Flow cytometry service providers
    • Private research institutes
    • Academia, research institutes, and government organizations
    • Venture capitalists and other public-private funding agencies
    • Pharmaceutical and biotechnology companies
    • Life Science Companies
    • Healthcare service providers (including hospitals and diagnostic centers)
    • Clinical research organizations (CROs)
    • Clinical testing laboratories and service providers

    Report Objectives

    • To define, describe, and forecast the global flow cytometry market based on offering, technology, application, end user, and region
    • To provide detailed information regarding the major factors influencing the growth of the market (such as drivers, restraints, challenges, and opportunities)
    • To strategically analyze micromarkets with respect to individual growth trends, prospects, and contributions to the overall flow cytometry market
    • To analyze opportunities in the market for stakeholders and provide details of the competitive landscape for market leaders
    • To forecast the size of the market segments with respect to six regions, namely, North America, Europe, Asia Pacific, Latin America, the Middle East, and Africa
    • To strategically profile the key players and comprehensively analyze their product portfolios, market positions, and core competencies
    • Track and analyze competitive developments such as acquisitions, product launches, expansions, agreements, partnerships, and R&D activities in the flow cytometry market.
    • To analyze and provide funding & investment activities, brand/product comparative analysis, and vendor valuation & financial metrics of the flow cytometry market.

     

    Get the Full Flow Cytometry Market Report

    Full forecast, segment splits, and company analysis for all Flow Cytometry Market.

    Download Sample Pages Buy Report

    METHODOLOGY

    Need a Tailored Report?

    Customize this report to your needs

    Get 10% FREE Customization

    Customize This Report
    Fact checked
    Cite this Research
    DMCA.com Protection Status